Pride of Bolivia Coffee (Coffea arabica)

Pride of Bolivia Coffee (Coffea arabica) is a specialty cultivar containing chlorogenic acids (36.81–55.75 mg/g in green beans) and caffeine (1.16–1.78 mg/g), which together modulate glucose metabolism and central nervous system stimulation. Its polyphenol content drives measurable antioxidant activity, though human clinical evidence specific to this cultivar remains absent.

Origin & History

Pride of Bolivia Coffee is a cultivar variant of Coffea arabica, likely referring to high-quality strains from Bolivian estates producing Bourbon-derived varieties. The green coffee beans are typically harvested and roasted for consumption, containing phenolic compounds, alkaloids, and roasting-derived melanoidins.

Historical & Cultural Context

No historical traditional medicine uses are documented for Pride of Bolivia Coffee specifically. Coffea arabica cultivation history is tied to estates like El Injerto (100% Bourbon variant), but this Bolivian cultivar lacks documented traditional medicinal applications.

Health Benefits

• Antioxidant activity demonstrated in vitro (DPPH IC50 values 2.22-2.59 mg/mL for roasted extracts) - preliminary evidence only
• Contains chlorogenic acids (36.81-55.75 mg/g in green beans) linked to metabolic effects - no human trials available
• Caffeine content (1.16-1.78 mg/g green beans) provides neurological stimulation - general coffee evidence only
• Phenolic compounds may modulate glucose and lipid metabolism - mechanistic evidence only
• Melanoidins formed during roasting (15.41-85.51 mg/g) show antioxidant potential - in vitro evidence only

How It Works

Chlorogenic acids in Pride of Bolivia Coffee—primarily 5-caffeoylquinic acid—inhibit glucose-6-phosphatase and slow intestinal glucose absorption by downregulating sodium-dependent glucose transporter 1 (SGLT1), contributing to postprandial glucose modulation. Caffeine antagonizes adenosine A1 and A2A receptors in the central nervous system, increasing dopamine and norepinephrine signaling to promote alertness and thermogenesis. Additionally, chlorogenic acids upregulate Nrf2-mediated antioxidant response element (ARE) transcription, inducing endogenous enzymes such as heme oxygenase-1 (HO-1) and superoxide dismutase (SOD).

Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on Pride of Bolivia Coffee were identified. General C. arabica studies focus only on chemical profiles and in vitro antioxidant activity, with broader coffee research linking chlorogenic acids to metabolic effects but no variant-specific human data available.

Clinical Summary

In vitro antioxidant testing of Pride of Bolivia roasted coffee extracts using the DPPH radical scavenging assay yielded IC50 values of 2.22–2.59 mg/mL, indicating moderate free-radical neutralization capacity, though this does not directly translate to in vivo efficacy. Phytochemical profiling of green beans confirmed chlorogenic acid concentrations of 36.81–55.75 mg/g, within the range associated with metabolic benefits observed in broader Coffea arabica research involving human cohorts. General Coffea arabica human trials suggest 200–400 mg/day of chlorogenic acids may improve fasting glucose and insulin sensitivity, but no randomized controlled trials have isolated Pride of Bolivia as the test cultivar. Evidence for this specific cultivar is currently limited to compositional and in vitro studies, and extrapolation from general coffee research should be made cautiously.

Nutritional Profile

Pride of Bolivia Coffee (Coffea arabica) green beans contain chlorogenic acids (CGA) as primary bioactive compounds at 36.81–55.75 mg/g dry weight, predominantly 5-caffeoylquinic acid (5-CQA), 3-CQA, and 4-CQA isomers. Caffeine alkaloid content ranges 1.16–1.78 mg/g in green beans (approximately 80–120 mg per standard 8 oz brewed cup equivalent). Trigonelline (a niacin precursor) is present at estimated 10–15 mg/g dry green bean, consistent with Arabica cultivars. Total phenolic content supports DPPH radical scavenging (IC50 2.22–2.59 mg/mL in roasted extracts). Roasting substantially reduces CGA content (30–70% loss depending on roast degree) while generating melanoidins and other Maillard reaction products with antioxidant activity. Macronutrient profile per 100g green beans: carbohydrates ~60g (primarily sucrose ~8g, polysaccharides including galactomannans and arabinogalactans ~50g), protein ~11–13g (rich in glutamic acid, aspartic acid), lipids ~15–17g (60% linoleic acid, 30% palmitic acid, with cafestol and kahweol diterpenes at ~5–10 mg/g). Mineral content includes potassium (~1,600–2,000 mg/100g), magnesium (~150–200 mg/100g), phosphorus (~150 mg/100g), manganese (~2 mg/100g), and trace copper. Niacin (B3) is generated from trigonelline degradation during roasting (~10–40 mg/100g roasted). Bioavailability note: CGA bioavailability is moderate (33–65% absorbed in small intestine); colonic microbiota ferment remainder into dihydrocaffeic and dihydroferulic acids. Diterpenes cafestol and kahweol are largely retained in unfiltered preparations but removed by paper filtration.

Preparation & Dosage

No clinically studied dosage ranges are available for Pride of Bolivia Coffee. Chemical analyses show caffeine content of 1.16-1.78 mg/g in green beans and 2.63-6.42 mg/g in roasted forms, with chlorogenic acids at 36.81-55.75 mg/g, but these are not standardized for clinical use. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Green tea extract, L-theanine, Rhodiola rosea, Cordyceps, Ashwagandha

Safety & Interactions

Caffeine content of 1.16–1.78 mg/g in green beans can cause insomnia, tachycardia, anxiety, and elevated blood pressure at high intake levels, particularly in caffeine-sensitive individuals. Pride of Bolivia Coffee may interact with monoamine oxidase inhibitors (MAOIs), anticoagulants such as warfarin (chlorogenic acids may modestly affect platelet aggregation), and antidiabetic medications by additively lowering blood glucose. Pregnant and breastfeeding women are advised to limit total caffeine intake to under 200 mg/day per major health guidelines, as excess caffeine is associated with low birth weight and preterm birth. Individuals with gastroesophageal reflux disease (GERD) or peptic ulcers should use caution, as chlorogenic acids can stimulate gastric acid secretion.